The ATF4-DDIT4-mTORC1 axis will inhibit the cancer therapy by activation of the autophagy signal pathway, and the combinatorial treatment with SIRT1/2 inhibitors and pharmacological autophagy inhibitors was an effective therapeutic strategy in lung cancer [10]. Here, SIRT1 is linked to lung carcinoma.